CHRISTINE ROBINSON: Open Payments
NPI 1992275788 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,670 in 84 payments from 13 companies in 2025. Trend: 2023 $2,008 · 2024 $1,812 · 2025 $1,670
Food & beverage: $1,502Education: $168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $386 |
| Janssen Biotech, Inc. | 9 | $310 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $261 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $151 |
| Celltrion USA Inc. | 5 | $125 |
| PFIZER INC. | 5 | $117 |
| Ardelyx, Inc. | 6 | $104 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Novo Nordisk Inc | 2 | $50 |
| Ipsen Biopharmaceuticals, Inc | 2 | $36 |
Products named: TREMFYA, RINVOQ, ENTYVIO, XIFAXAN, VEGZELMA, IBSRELA, EOHILIA, XELJANZ.
Industry payments across VA — which companies pay providers there.
